A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
This is a research study for participants who have been diagnosed with lung cancer and are receiving VATS (Video Assisted Thoracoscopic Surgery) lobectomy or segmentectomy. The overall objective of this study is to develop a database to collect data on participants who are undergoing VATS lobectomy or segmentectomy for lung cancer.
Checked against the public recordLast updated Jan 13, 2020 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Dana-Farber Cancer Institute
- Interventions being studied
- Other: VATS-associated best practices
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Male and female subjects * Age ≥ 18 years * Underwent a VATS lobectomy or segmentectomy procedure for lung cancer -- Note: patients with other malignancies are eligible if they have a primary cancer of the lung as defined above Exclusion Criteria: * Subjects undergoing thoracotomy lobectomy or segmentectomy for lung cancer * Subjects undergoing surgical procedures other than VATS lobectomy or segmentectomy for lung cancer
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- Providence Saint John's Health CenterSanta Monica, California
- Georgetown University Medical CenterWashington D.C., District of Columbia
- WellStar Medical GroupAustell, Georgia
- North Shore University Health SystemEvanston, Illinois
- Brigham and Women's HospitalBoston, Massachusetts
- Washington University in St. LouisSt Louis, Missouri
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jan 13, 2020. Always confirm current availability with the study team.